This is one of the better-evidenced bridge strategies described in the source material, though it is still not studied as a complete package.

The levonorgestrel IUD is well studied both for contraception and for controlling heavy bleeding, and separately it is well studied for protecting the uterine lining when estrogen is added, so each piece has solid evidence behind it. What has not been directly studied is the whole strategy, IUD plus a separately added estrogen patch or gel, compared against continuing a combined pill. One important detail that is easy to miss: if you add estrogen to your IUD, it needs to be changed every five years for endometrial protection, even if it is otherwise approved for longer as a contraceptive alone.

What to know about this answer

There is broad convergence among clinicians in the source material that pairing an IUD with a separately added estrogen is a reasonable bridge, but this agreement is about clinical practice, not trial evidence; the disagreement worth flagging is really between the well-studied individual pieces and the untested combination.

What the research shows, and which source each finding rests on

In a randomized trial of 571 women with heavy menstrual bleeding, the levonorgestrel IUD improved bleeding-related quality of life significantly more than usual medical treatment, and at 2 years, 64% of IUD users were still using their treatment versus 38% on usual medical treatment.

B[1]

A systematic review of six randomized trials found the levonorgestrel IUD at least as effective as other methods of delivering progestogen for protecting the uterine lining in women also using estrogen therapy.

A[2]

For contraception, a 52 mg levonorgestrel IUD inserted at age 45 or older can be used until age 55; but if estrogen is later added for endometrial protection as part of hormone therapy, the device must be changed every 5 years regardless of when it was originally inserted.

A[3]

An IUD releases its hormone locally to the uterus rather than throughout the body, so unlike a combined pill it does not suppress FSH systemically, which means a woman over 50 using an IUD can potentially get an interpretable FSH reading, unlike a woman on a combined pill.

A[3]

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

the components are proven, so the combination is a sound bridge strategy

clinicians describing this approach in the source material

Because the IUD's contraceptive effect, its bleeding control, and its endometrial protection alongside estrogen are each separately and directly studied, combining an IUD with a systemic estrogen patch, spray, or gel is presented as the best-evidenced of the available bridge options.

E[4]

the strategy as a whole remains unstudied

the underlying evidence base itself

No trial has tested the IUD-plus-estrogen combination as a strategy against continuing a combined pill, so while each ingredient is well studied on its own, the combination's overall performance for symptom control, safety, and satisfaction has not been measured.

A[3]

What would settle it: A trial directly comparing the IUD-plus-transdermal-estrogen strategy against continued combined pill use in perimenopausal women, for contraception, bleeding, symptom control, and safety, would settle this. It has not been run.

What is really going on here

  1. The 5-year replacement rule for endometrial protection applies the moment estrogen is added, and it is easy to lose track of if you are used to your IUD's longer approved contraceptive lifespan.
  2. The strategy as a package, IUD plus added estrogen, has not been tested against simply continuing a combined pill, even though its individual components are well studied.

Questions for your doctor

  1. If I add estrogen to my IUD, when does the 5-year replacement clock start?
  2. Would this combination give me both contraception and symptom relief, or just one of those?
  3. Since my IUD does not suppress my hormones the way a pill would, could we use my FSH to help figure out where I am in the transition?
  4. What form of estrogen would you add, and how would we monitor whether it is working?

Questions with no answer yet

Does the IUD-plus-transdermal-estrogen bridge strategy actually perform as well, for symptom control, safety, and satisfaction, as simply continuing a combined pill, even though each individual component is separately well studied?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The IUD's contraceptive effect, bleeding control, and endometrial protection alongside estrogen are each separately and directly studied, but no trial has tested the combination as a strategy against continuing a combined pill.

What would test it: A trial directly comparing the IUD-plus-transdermal-estrogen strategy against continued combined pill use in perimenopausal women, for contraception, bleeding, symptom control, and safety.

Does the levonorgestrel absorbed systemically from a 52 mg IUD carry the same breast cancer signal seen with oral levonorgestrel-containing regimens, or is the systemic exposure too low to matter?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: Systemic exposure from the 52 mg levonorgestrel IUD is low but not zero, and the source material states directly that whether it carries the breast risk seen with oral levonorgestrel-containing regimens has not been established.

What would test it: A study measuring breast cancer risk specifically in long-term 52 mg levonorgestrel IUD users compared with non-users and with oral levonorgestrel users.

Sources

  1. 1.Levonorgestrel intrauterine system versus medical therapy for menorrhagia.Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J (ECLIPSE Trial Collaborative Group). Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med 2013;368(2):128-37. · Randomised trial
  2. 2.The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review.Wan YL, Holland C. The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review. Climacteric 2011;14(6):622-32. · Systematic review or guideline
  3. 3.FSRH. Contraception for Women Aged Over 40 Years, Section 7.1.2; FSRH. Intrauterine Contraception, March 2023 (amended).Systematic review or guideline
  4. 4.Heather Hirsch, MD. Is Your Birth Control Making Perimenopause Worse? When to Switch to HRT (video transcript).Review, opinion or mechanism

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions

Related guides